Digest Network Come funziona
Network
/
Società
Al
Non verificato

Alpha Cognition Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMercato azionarioSaluteSanità

54 comunicati stampa

Guarda tutti i comunicati
09/09/2026
Mercato azionario
Finanza
Biotecnologia
Farmaceutica
Salute
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Alpha Cognition Inc.
Emittente
Business Wire
1.00
0
01/09/2026
Biotecnologia
Farmaceutica
Salute
Mercato azionario
Finanza
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Alpha Cognition Inc.
Emittente
Business Wire
1.00
0
13/08/2026
Salute
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
Web e Social Network
Telefonia e Varie
Mercato azionario
Alpha Cognition Inc. Reports Second Quarter 2026 Financial Results and Provides Operational Update
Fonte
Alpha Cognition Inc.
Emittente
Business Wire
1.00
0
03/08/2026
Salute
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
Mercato azionario
Finanza
Web e Social Network
Telefonia e Varie
Alpha Cognition to Report Second Quarter 2026 Financial Results and Provide Business Update
Fonte
Alpha Cognition Inc.
Emittente
Business Wire
1.00
0
29/07/2026
Biotecnologia
Farmaceutica
Salute
Industria
Alpha Cognition Receives European Patent Covering ZUNVEYL® for the Treatment of Mild-to-Moderate Alzheimer’s Disease
Fonte
Alpha Cognition Inc.
Emittente
Business Wire
1.00
0
10/07/2026
Salute
Scienza
Farmaceutica
Biotecnologia
Eventi
Alpha Cognition to Participate in Panel Discussion at the B. Riley Securities Mind, Muscle & Vision Summit
Fonte
Alpha Cognition Inc.
Emittente
Business Wire
1.00
0
23/06/2026
Mercato del lavoro
Biotecnologia
Farmaceutica
Salute
Alpha Cognition Announces Election of Dr. Robert Wills as Chairman of the Board
Fonte
Alpha Cognition Inc.
Emittente
Business Wire
1.00
0
09/06/2026
Salute
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
Industria
Alpha Cognition Reports Positive Top-Line Results from BEACON Real-World Study of ZUNVEYL® in Alzheimer’s Disease
Fonte
Alpha Cognition Inc.
Emittente
Business Wire
1.00
0
14/05/2026
Salute
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
Web e Social Network
Telefonia e Varie
Mercato azionario
Alpha Cognition Inc. Reports First Quarter 2026 Financial Results and Provides Operational Update
Fonte
Alpha Cognition Inc.
Emittente
Business Wire
1.00
0
28/04/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Alpha Cognition (Nasdaq: ACOG) to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, May 14, 2026
Fonte
Alpha Cognition Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0